Nanodiamonds: Next generation nano-theranostics for cancer therapy
Cancer Letters · 2024-04 · 587 · 216710
DOI: 10.1016/j.canlet.2024.216710 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Letters, 2024-04. Verfasst von Nivedita Priyadarshni und 2 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Biology Research and Training, Department of Biological Sciences, Alabama State University, Montgomery, AL, USA. Hauptthemen laut MEDLINE: Nanodiamonds, Neoplasms. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NIGMS NIH HHS, National Science Foundation.
Abstract (Originalsprache)
Cancer remains a leading global cause of mortality, demanding early diagnosis and effective treatment. Traditional therapeutic methods often fall short due to their need for more specificity and systemic toxicity. In this challenging landscape, nanodiamonds (ND) emerge as a potential solution, mitigating the limitations of conventional approaches. ND are tiny carbon particles that mimic traditional diamonds chemical stability and hardness and harness nanomaterials' advantages. ND stands out for the unique properties that make them promising nanotheranostics candidates, combining therapeutic and imaging capabilities in one platform. Many of these applications depend on the design of the particle's surface, as the surface's role is crucial in transporting bioactive molecules, preventing aggregation, and building composite materials. This review delves into ND's distinctive features, structural and optical characteristics, and their profound relevance in advancing cancer diagnosis and treatment methods. The report delves into how these exceptional ND properties drive the development of state-of-the-art techniques for precise tumor targeting, boosting the effectiveness of chemotherapy as a chemosensitizer, harnessing immunotherapy strategies, facilitating precision medicine, and creating localized microfilm devices for targeted therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cancer Biology Research and Training, Department of Biological Sciences, Alabama State University, Montgomery, AL, USA.
- Microbiology, Biochemistry, and Immunology, Cancer Health Equity Institute, Morehouse School of Medicine, Atlanta, GA, USA.
- Cancer Biology Research and Training, Department of Biological Sciences, Alabama State University, Montgomery, AL, USA. Electronic address: mmishra@alasu.edu.
Förderung
- NIA NIH HHS
- NIGMS NIH HHS
- National Science Foundation
- American Cancer Society
- National Institutes of Health
Zitieren
APA
Priyadarshni, N., Singh, R., & Mishra, M. K. (2024). Nanodiamonds: Next generation nano-theranostics for cancer therapy. Cancer Letters, 587, 216710. https://doi.org/10.1016/j.canlet.2024.216710
Vancouver
Priyadarshni N, Singh R, Mishra MK. Nanodiamonds: Next generation nano-theranostics for cancer therapy. Cancer Letters. 2024;587:216710. doi:10.1016/j.canlet.2024.216710
BibTeX
@article{Priyadarshni2024,
author = {Priyadarshni, Nivedita and Singh, Rajesh and Mishra, Manoj K},
title = {Nanodiamonds: Next generation nano-theranostics for cancer therapy},
journal = {Cancer Letters},
year = {2024},
volume = {587},
pages = {216710},
doi = {10.1016/j.canlet.2024.216710}
}
EUVIMED